HARVARD BIOSCIENCE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $150.00K.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $0.00.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $15.00K.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $13.00K, a 96.79% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $43.00K, a 91.50% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $506.00K, a 368.52% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $108.00K, a 96.25% decline from fiscal 2021.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $2.88M, a 793.48% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $150.00K 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $43.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $15.00K 10-Q · filed 2025-11-06 | $40.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $13.00K 10-Q · filed 2025-08-11 | $25.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $15.00K 10-Q · filed 2025-05-12 | $417.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $506.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $510.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $405.00K 10-Q · filed 2024-08-08 | $574.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $104.00K 10-Q · filed 2024-05-07 | $181.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $108.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $64.00K 10-Q · filed 2023-11-07 | $277.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $12.00K 10-Q · filed 2023-08-08 | $363.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $31.00K 10-Q · filed 2022-05-04 | $984.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.88M 10-K · filed 2023-03-09 |
| 2021-09-30 | $150.00K 10-Q · filed 2022-11-09 | $3.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $633.00K 10-Q · filed 2022-08-04 | $2.86M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.92M 10-Q · filed 2022-05-04 | $2.25M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $322.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $19.00K 10-Q · filed 2021-08-06 | |
| 2019-12-31 | $11.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $11.00K 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $46.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $3.19M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $8.00K 10-Q · filed 2020-05-08 | $4.36M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $5.17M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.14M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $1.17M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $817.00K 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $190.00K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $171.00K 10-K · filed 2018-03-16 | |
| 2015-12-31 | $2.63M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $2.16M 10-K · filed 2017-03-17 | |
| 2013-12-31 | $4.05M 10-K · filed 2016-04-29 | |
| 2012-12-31 | $2.12M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $400.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $128.00K 10-K · filed 2013-03-18 | |
| 2009-12-31 | $171.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |